- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Japan streamlines embryonic stem cell reviews
21 August 2009 11:11 am
TOKYO—Research involving human embryonic stem (ES) cells will become easier in Japan as a result of new ethical review requirements that take effect today.
Previously, research groups had to get approval for each project involving human ES cells from their own Institutional Review Board (IRB) and then from a national committee under the Ministry of Education, Culture, Science, Sports, and Technology. This two-step process took 3 months or more, frustrating researchers trying to keep up with a fast-moving field. Even simply adding members to a research team required this dual approval.
The new policy drops the national level review requirement. Institutions must still inform the ministry of each project. "But the researchers can start work as soon as the project is approved by the IRB," says Junichi Iwata, deputy director of the ministry's office of bioethics and safety.
The changes put more responsibility in the hands of team leaders and their IRB, says Shin-ichi Nishikawa, a stem cell researcher at the RIKEN Center for Developmental Biology in Kobe. Groups planning to derive human ES cells still need both institutional and national reviews of their plans and there are strict requirements for informed consent by embryo donors. Nishikawa, who chairs the education ministry's review committee, says continuing scrutiny of ES cell derivation is warranted because of concerns about handling tissue "with the potential to become a human being." So far only two Japanese groups have been authorized to derive human embryonic stem cells; one group has actually done so.
Nishikawa says some 30 groups have permission for 50 or so projects involving human ES cells. Many researchers are now focusing on induced pluripotent (iPS) cells, which can be derived without sacrificing an embryo. One of the last researchers to go through the two-stage approval process was Shinya Yamanaka, the Kyoto University researcher who first reported the derivation of iPS cells. Nishikawa believes Yamanaka is planning to compare the characteristics of iPS and ES cells, a theme Nishikawa expects other groups to take up as well.